Our Directors
Prof Andrew Scott AM
Director, Department of Molecular Imaging and Therapy, Austin Health
Head, Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute (ONJCRI)Co-Director, Centre for Research Excellence in Brain Cancer, ONJCRI National Imaging Facility, ONJCRI/La Trobe Node Director
Prof. Andrew Scott is Director, Department of Molecular Imaging and Therapy, Austin Health; leads the Tumour Targeting Laboratory at the Olivia Newton-John Cancer Research Institute and co-Director, Centre for Research Excellence in Brain Cancer; and is Professor, La Trobe University and The University of Melbourne.
His clinical and research interests are focused on developing innovative strategies for targeted therapy of cancer (particularly with monoclonal antibodies), molecular imaging in oncology, and global advocacy in Oncology and Nuclear Medicine.
His laboratory has been involved in the preclinical development and first-in-man trials of numerous recombinant antibodies in cancer patients, and seven antibodies developed in his laboratory have been licenced to Biotech and Pharma companies, and have entered Phase I/II/III trials.
He has published over 500 peer reviewed papers and 27 book chapters, is an inventor on 25 patents, and is a founder of a biotech company.
Prof Scott is actively involved in the training and mentoring of young scientists and clinicians, and is currently supervising several doctoral students, postdoctoral fellows and nuclear medicine trainees.
Another focus of his work is strategic planning for training, health care policy, and molecular imaging and nuclear medicine therapy advocacy within the US, European, South American, Asia-Oceania, and African regions, as well as with the IAEA and WHO and he also participates in policy and governance activities with the Australian Government.
Prof Scott is former president of the World Federation of Nuclear Medicine and Biology, the peak global nuclear medicine organisation.
Awards:
2017 Member (AM) in the General Division of the Order of Australia, and elected a Fellow of the Australian Academy of Health and Medical Sciences.2022 The Saul Hertz award from SNNMI and Ajit Padhy award from WARMTH.2023 Telix Award from ANZSNM.2024 Elected Fellow, Society of Nuclear Medicine and Molecular Imaging, USA.
A/Prof Michael Nguyen (MBBS FRACP M.Phil)
Leading interventional cardiologist A/Prof Michael Nguyen completed his cardiology training in Melbourne, Australia and then undertook fellowship training in interventional cardiology and peripheral vascular interventions at Beth Israel Deaconess Medical Centre/Harvard Medical School in Boston, USA.
He is currently an Associate Professor at the University of Western Australia and has an academic appointment with the University of Notre Dame School of Medicine.
He specialises in transcatheter aortic valve implantation (TAVI) and complex coronary and structural interventions (left atrial appendage occlusion, ASD/PFO closure), and is widely recognised as a clinical leader in these fields across the Asia-Pacific region.
His academic contributions extend to research, where he has served as Head of Clinical Trials in the Department of Cardiology, overseeing numerous groundbreaking studies.
As a cardiologist in Perth who has dedicated his career to the care of his patients as well as medical research and teaching/mentoring, he is also the General Partner and Director for FUND WA, where he brings core life sciences experience to the Fund WA team, increasing the Manager’s capability across life sciences.
Michael has been a leader in cardiovascular research, including medical technology and cardiovascular device assessment and commercial implementation. He has been on advisory boards for several cardiovascular device and pharmaceutical companies including Boston Scientific, Medtronic and Abbott Vascular. He is currently also the Director of Clinical Trials and Research in the Department of Cardiology at Fiona Stanley Hospital.
He is a key opinion leader in the Asia-Pacific region and has been on the organising committee and faculty for many international and national conferences. He is passionate about supporting start-ups in the medical technology space and transitioning technology from bench to clinical practice and commercialisation.
Michael has also been a significant supporter of local startups and has invested at seed stage funding for several companies including lead investor for VitalTrace. Michael has also started several businesses of his own including one for the busiest cardiology companies in WA (Access Cardiology Pty Ltd) and a thriving sales and distribution company (Tyreline Australia Pty Ltd) for which he is a Director.
https://www.fundwa.com.au/aboutmichaelnguyen
https://www.accesscardiology.com.au/a-prof-michael-nguyen
Prof Paul Parizel
Graduated as MD, in 1982, summa cum laude from the Faculty of Medicine, University of Antwerp, Belgium. 1994 obtained a PhD with a doctoral dissertation entitled “The influence of field strength on magnetic resonance imaging.”
Board-certified radiologist and neuroradiologist and completed fellowships in neuroradiology at Massachusetts General Hospital, Harvard Medical School, and at Hôpital Erasme, University of Brussels.
Received the prestigious “Schinz Medal” from the Swiss Society of Radiology (SSR, 2018) and was awarded the Gold Medal of the European Society of Radiology (ESR, 2021) in recognition of his outstanding, internationally recognised achievements and leadership in the areas of neuroradiology and artificial intelligence. He is a member-at-large of the Executive Committee of the World Federation of Neuroradiological Societies (WFNRS, 2022-2026).
Since 2019, prof. Parizel works in Australia as the “David Hartley Chair of Radiology”, with an academic appointment at the University of Western Australia (UWA) and a part-time clinical appointment at Royal Perth Hospital (RPH). He is the Chair of the Clinical Radiology Research Committee (CRRC) of the Royal Australian and New Zealand College of Radiology (RANZCR), Director of the Western Australian National Imaging Facility node, a member of the Academic Council at the University of Western Australia, and a member of the Centre for Innovation in Biomedical Imaging Technology Advisory Committee.
2010 to 2012, served as President of the European Society of Neuroradiology (ESNR). He was elected President (2016-2017) and Chairman of the Board of Directors (2017-2018) of the European Society of Radiology (ESR). He is an Honorary Fellow of the Royal Australian and New-Zealand College of Radiology (2002), Honorary and Founding member of Russian National Society of Neuroradiology (2012), Honorary Member of the European Society of Neuroradiology (2016), Honorary Member of the American Society of Neuroradiology (2017), Honorary Member of the Radiological Society of North America (2018), and Honorary Member of the Serbian, Romanian, Spanish, Hellenic, French, Iranian, Israeli, Algerian, Swiss, Cuban, Italian, Peruvian, and Brazilian societies of radiology.
Prof. Parizel has authored or co-authored well over 400 peer-reviewed scientific papers, more than 40 book chapters, and has edited or co-edited several textbooks. His h-index is 50 (Scopus) and his scientific work has been cited over 9,000 times.
He remains a corresponding member of the Royal Academy of Medicine of Belgium and has been a member of the Harvard Club for more than thirty years.
Mr Ferdinand Azis
Ferdinand Azis is the Managing Director of Alphabright Capital, a sector agnostic investment company with a focus on research and/or technology-led solutions in investing.
Ferdinand has over 15 years of experience in equity capital markets and cross-border mergers and acquisitions and has worked in Australia and Singapore. He has managed trading books and equity portfolios of equity firms and advised a number of strategic investors, including some of the biggest Japanese trading houses wanting to invest in the South East Asia region.
He is a passionate advocate of youth development and is the co-founder of not-for-profit organisation, Australia Oikos Care (AOC), a deductible gift recipient (DGR) licensed foundation that aims to empower young people through education in order to alleviate poverty in some areas in Indonesia.
In 2025, Australia Oikos Care (AOC) has been nominated as finalists in two categories: Fundraising Excellence and Small Charity of the Year awards at the Third Sector Awards 2025.
Ferdinand is a member of the Board of Trustee of the Foundation of Christ Church Grammar School. He holds a Bachelor of Commerce degree, with First Class Honours in Finance, from the University of Western Australia.
He is married with three children. He has a son at Christ Church Grammar School and two daughters at St Hilda’s Anglican School for Girls.
https://www.ccgs.wa.edu.au/about-us/governance/council
https://www.australiaoikoscare.org/#contact-us